학술논문
A Phase II Clinical Trial of E7820 for Patients with Relapsed/Refractory Myeloid Malignancies with Mutations in Splicing Factor Genes
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:9065-9067
Subject
Language
ISSN
0006-4971